PTEN and metastatic colorectal cancer: In patients with metastatic colorectal cancer (mCRC), PTEN gene mutation has been reported in 2–20%, with higher rates in microsatellite stable groups [5], while loss of PTEN protein has been reported in 13–55% [6–10].